Key Opinion Leader – Ultherapy (Global)
Dr. Stephen Lowe serves as a distinguished Key Opinion Leader (KOL) for Ultherapy, a cutting-edge non-invasive procedure designed to lift and tighten skin and soft tissues using micro-focused ultrasound with visualisation technology. His influential role revolves around substantiating the efficacy and benefits of Ultherapy through clinical research, medical journal publications, and on-stage presentations.
With a robust background in public health and aesthetic medicine, Dr. Lowe has conducted pivotal studies that demonstrate how Ultherapy stimulates collagen production deep within the skin and fibrous network resulting in visible improvements in skin laxity, firmness and lift. His research not only contributes to the scientific understanding of Ultherapy’s mechanisms of action but also underscores its effectiveness as a viable alternative to surgical facelifts for those individuals not ready to take that step.
Since 2021, Dr Lowe was requested to join the Ultherapy Taskforce, a global enterprise of only ten renowned scientists, physicians and surgeons selected due to their expert knowledge and experience of Ultherapy. Together, they have provided direction and guidance for the future of Ultherapy including treatment protocols, safety considerations and future technological developments.
As a passionate educator, Dr. Lowe plays a crucial role in training fellow physicians, nurses and dermal clinicians on the proper techniques and best practices for administering Ultherapy. His expertise ensures that practitioners across the globe can deliver consistent, safe and optimal outcomes for their patients, thereby advancing the field of non-invasive cosmetic procedures.
Dr. Lowe’s advocacy for Ultherapy extends beyond the medical community. He actively engages in public speaking engagements, webinars, and media appearances to educate patients about the benefits of Ultherapy and to dispel misconceptions about non-invasive treatments. By fostering a deeper understanding and appreciation for Ultherapy’s capabilities, Dr. Lowe empowers individuals to make informed decisions about their skincare and aesthetic goals.
Dr. Lowe’s advocacy for Ultherapy extends beyond the medical community. He actively engages in public speaking engagements, webinars, and media appearances to educate patients about the benefits of Ultherapy and to dispel misconceptions about non-invasive treatments. By fostering a deeper understanding and appreciation for Ultherapy’s capabilities, Dr. Lowe empowers individuals to make informed decisions about their skincare and aesthetic goals.
In essence, Dr. Stephen Lowe’s work as a KOL for Ultherapy exemplifies his commitment to advancing the field of aesthetic medicine through research, education, and advocacy, ultimately enhancing patient care and treatment satisfaction worldwide.
Key Speaking Events
Bangkok, Thailand 17/02/2023
Achieving Optimal outcomes for skin quality improvement through See Plan Treat. Ultherapy Thailand: Seeing Matters
Merz
Melbourne, Australia 25/02/2022
Can single treatment, single depth superficial 1.5mm MFU-V be used for rhytid improvement? ASCD
Merz
Virtual. Global 20/11/2021
Current thinking on biostimulation: MFU-V for accordian lines Merz Aesthetics Expert Summit (Global) “Panel discussion”
Merz
Virtual. USA 11/07/2021
Can single treatment, single treatment, single depth superficial 1.5mm MFU-V be used for rhytid improvement? IMCAS Asia
Merz
Virtual. USA 15/05/2021
Poster: Can single treatment, single depth superficial 1.5mm MFU-V be used for rhytid improvement? ASLMS
Merz
Virtual, Australia 13/11/2020
Evaluation of superficial MFU for the improvement of periorbital, perioral vertical and accordion lines. Non-Surgical Symposium
Merz
Parramatta, Sydney 20/10/2019
Ultherapy for brow rejuvenation The Masters Series: JJ Tour of Aesthetics
Merz
Sydney, Australia 05/04/2019
Ultherapy as a foundation treatment Cosmetex “Panel discussion”
Merz
Sydney, Australia 14/03/2019
Ultherapy as a foundation treatment Cosmedicon
Merz